EHC

Encompass Health Corporation [EHC] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

EHC Stock Summary

Top EHC Correlated Resources

EHC


Top 10 Correlated ETFs

EHC


Top 10 Correlated Stocks

EHC


In the News

10:46 29 Mar 2024 EHC

Encompass Health (EHC) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

10:51 29 Mar 2024 EHC

Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

01:51 29 Mar 2024 EHC

Encompass Health (EHC) Up 42% in a Year: What Lies Ahead?

Encompass Health (EHC) remains well-poised for growth on the back of sustained top-line growth, an expanding healthcare facility portfolio and robust cash-generating abilities.

12:16 29 Mar 2024 EHC

An In-Depth Analysis of Encompass Health's (EHC) 2024 Outlook

Growth in Medicare and Managed Care pricing, along with capacity additions of six de novos with 280 beds, will likely have an impact on Encompass Health's (EHC) 2024 bottom line.

01:51 29 Mar 2024 EHC

Encompass Health (EHC), Piedmont to Build Loganville Facility

Encompass Health (EHC) partners with Piedmont to construct a 40-bed inpatient rehabilitation hospital in Georgia to better serve the rehabilitative care needs of the state and solidify its footprint.

10:46 29 Mar 2024 EHC

Here's Why Encompass Health (EHC) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

07:45 29 Mar 2024 EHC

Encompass Health to present at Barclays Global Healthcare Conference

BIRMINGHAM, Ala. , March 5, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the Barclays Global Healthcare Conference, which is being held in Miami, Florida, on March 12-14, 2024.

01:01 29 Mar 2024 EHC

Encompass Health (EHC) Upgraded to Buy: What Does It Mean for the Stock?

Encompass Health (EHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

10:46 29 Mar 2024 EHC

Why Encompass Health (EHC) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

10:31 29 Mar 2024 EHC

4 Stocks to Watch in a Resilient Outpatient Home Health Industry

The rising dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain.

EHC Financial details

Company Rating
Strong Buy
Market Cap
7.66B
Income
352M
Revenue
4.8B
Book val./share
16.56
Cash/share
1.43
Dividend
0.6
Dividend %
0.88%
Employees
22.36K
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
19.2
Forward P/E
19.14
PEG
6.7
P/S
1.46
P/B
4.35
P/C
57.57
P/FCF
26.34
Quick Ratio
0.99
Current Ratio
1.27
Debt / Equity
1.47
LT Debt / Equity
1.03
-
-
EPS (TTM)
3.5
EPS next Y
4.3
EPS next Q
0.97
EPS this Y
29.04%
EPS next Y
22.95%
EPS next 5Y
58.86%
EPS last 5Y
-0.83%
Revenue last 5Y
0.84%
Revenue Q/Q
3.31%
EPS Q/Q
1.18%
-
-
-
-
SMA20
4%
SMA50
13.04%
SMA100
25.81%
Inst Own
70.19%
Inst Trans
0.76%
ROA
6%
ROE
25%
ROC
0.11%
Gross Margin
95%
Oper. Margin
13%
Profit Margin
8%
Payout
17%
Shs Outstand
100.14M
Shs Float
98.61M
-
-
-
-
Target Price
88.25
52W Range
51.3-78.11
52W High
+5.54%
52W Low
+61.41%
RSI
63
Rel Volume
2.36
Avg Volume
604.95K
Volume
1.43M
Perf Week
7.37%
Perf Month
11.57%
Perf Quarter
26.57%
Perf Half Y
17.5%
-
-
-
-
Beta
0.832
-
-
Volatility
1.94%, 1.66%
Prev Close
5.93%
Price
82.32
Change
6.26%

EHC Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
46.9947.151.7343.8448.25
Net income per share
3.662.884.162.733.54
Operating cash flow per share
6.487.157.237.118.55
Free cash flow per share
2.363.011.661.232.69
Cash per share
0.972.270.550.221.43
Book value per share
13.816.1119.3113.2116.56
Tangible book value per share
-8.66-7.59-4.513.197.41
Share holders equity per share
13.816.1119.3113.2116.56
Interest debt per share
35.7837.837.431.9425.88
Market cap
5.4B6.49B5.14B5.93B6.64B
Enterprise value
8.65B9.81B8.62B8.9B9.47B
P/E ratio
15.0622.8212.4721.8918.86
Price to sales ratio
1.171.411.361.38
POCF ratio
8.59.27.188.417.8
PFCF ratio
23.3621.8731.2348.7524.8
P/B Ratio
3.994.082.694.534.03
PTB ratio
3.994.082.694.534.03
EV to sales
1.882.111.682.051.97
Enterprise value over EBITDA
9.1210.847.9910.229.41
EV to operating cash flow
13.6213.9112.0512.6111.13
EV to free cash flow
37.4333.0752.3973.1635.37
Earnings yield
0.070.040.080.050.05
Free cash flow yield
0.040.050.030.020.04
Debt to equity
2.482.231.852.281.47
Debt to assets
0.550.550.520.530.4
Net debt to EBITDA
3.433.673.233.412.81
Current ratio
1.051.321.231.251.28
Interest coverage
4.573.5953.574.66
Income quality
1.421.911.381.932.35
Dividend Yield
0.020.020.020.020.01
Payout ratio
0.30.390.270.370.17
Sales general and administrative to revenue
0.630.630.620.60.6
Research and developement to revenue
00000
Intangibles to total assets
0.460.430.410.270.26
Capex to operating cash flow
-0.64-0.58-0.77-0.83-0.69
Capex to revenue
-0.09-0.09-0.11-0.13-0.12
Capex to depreciation
-1.85-1.68-2.15-2.4-2.13
Stock based compensation to revenue
0.020.010.010.010.01
Graham number
33.7132.3242.5328.4936.3
ROIC
0.120.10.110.110.12
Return on tangible assets
0.110.080.10.070.08
Graham Net
-37.19-38.11-39.07-33.61-32.21
Working capital
34.8M231.3M172.6M141.3M185.4M
Tangible asset value
-848.8M-748.4M-446.2M316.4M737.7M
Net current asset value
-3.39B-3.5B-3.54B-3.06B-2.96B
Invested capital
2.482.231.852.281.47
Average receivables
486.9M539.45M626.55M608.55M574.2M
Average payables
92.3M104.8M126.3M135.25M151.45M
Average inventory
58.2M61.4M65.25M48.35M15.8M
Days sales outstanding
40.1145.0248.4845.0646.5
Days payables outstanding
205.65209.35239.96240.0216.04
Days of inventory on hand
124.78119.06113.5357.070
Receivables turnover
9.18.117.538.17.85
Payables turnover
1.771.741.521.5222.75
Inventory turnover
2.933.073.226.40
ROE
0.270.180.220.210.21
Capex per share
-4.12-4.14-5.57-5.89-5.86

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
11.4511.6711.9312.1312.53
Net income per share
0.90.880.920.860.88
Operating cash flow per share
1.732.292.082.162.02
Free cash flow per share
-0.31.320.90.69-0.22
Cash per share
0.221.151.511.381.43
Book value per share
13.213.9214.8315.6816.56
Tangible book value per share
3.194.085.116.357.41
Share holders equity per share
13.213.9214.8315.6816.56
Interest debt per share
30.5130.2929.929.7624.65
Market cap
5.94B5.38B6.74B6.68B6.64B
Enterprise value
8.91B8.27B9.56B9.51B9.47B
P/E ratio
16.6115.3318.4319.5918.95
Price to sales ratio
5.224.635.685.545.32
POCF ratio
34.4923.632.5931.0533.03
PFCF ratio
-201.3340.9675.2897.55-307.34
P/B Ratio
4.533.894.574.284.03
PTB ratio
4.533.894.574.284.03
EV to sales
7.837.128.057.887.59
Enterprise value over EBITDA
35.433.5436.7538.3136.41
EV to operating cash flow
51.7436.2746.2444.1847.1
EV to free cash flow
-302.0262.96106.8138.8-438.3
Earnings yield
0.020.020.010.010.01
Free cash flow yield
00.020.010.010
Debt to equity
2.282.151.991.871.47
Debt to assets
0.530.520.50.490.4
Net debt to EBITDA
11.811.7210.8511.3810.88
Current ratio
1.251.291.261.271.28
Interest coverage
5.025.023.263.195.44
Income quality
1.471.991.751.882.09
Dividend Yield
00000
Payout ratio
0.170.180.160.180.17
Sales general and administrative to revenue
0.590.590.590.60.04
Research and developement to revenue
00000
Intangibles to total assets
0.270.270.260.260.26
Capex to operating cash flow
-1.17-0.42-0.57-0.68-1.11
Capex to revenue
-0.18-0.08-0.1-0.12-0.18
Capex to depreciation
-3.19-1.51-1.61-2.18-3.18
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
16.3516.6217.5117.3918.11
ROIC
0.030.030.020.020.03
Return on tangible assets
0.020.020.020.020.02
Graham Net
-33.58-32.86-32.52-32.32-32.21
Working capital
141.3M169.6M169M174.5M185.4M
Tangible asset value
316.4M405.3M508.2M631.5M737.7M
Net current asset value
-3.06B-3.02B-2.98B-2.96B-2.96B
Invested capital
2.282.151.991.871.47
Average receivables
518.45M525.65M523.4M534.1M573.75M
Average payables
133.5M137M148.45M160.6M167.7M
Average inventory
37.95M32.95M35.4M39M20.75M
Days sales outstanding
42.4839.940.3639.9644.15
Days payables outstanding
221.91236.04269.65276.1815.24
Days of inventory on hand
52.7657.3863.1769.290
Receivables turnover
2.122.262.232.252.04
Payables turnover
0.410.380.330.335.9
Inventory turnover
1.711.571.421.30
ROE
0.070.060.060.050.05
Capex per share
-2.03-0.97-1.18-1.47-2.24

EHC Frequently Asked Questions

What is Encompass Health Corporation stock symbol ?

Encompass Health Corporation is a US stock , located in Birmingham of Al and trading under the symbol EHC

Is Encompass Health Corporation buy or a sell ?

4 stock analysts have 4 predictions with a medium analyst target price of $88.25. The lowest prediction is $83 and the highest is $100

What is EHC stock prediction ?

What is Encompass Health Corporation stock quote today ?

Encompass Health Corporation stock price is $82.32 today.

Is Encompass Health Corporation stock public?

Yes, Encompass Health Corporation is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap